Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yanbian Yiqiao Biochemistry Pharmaceutical Co., Ltd. (YYB) was a pharmaceutical manufacturing company based in Yanji, Jilin Province, China. Established in 1998, the company specialized in the production of herbal extracts and biochemical pharmaceutical products, maintaining a portfolio of over 80 products. In 2006, it was acquired by Jade Pharmaceutical Inc., which subsequently became a subsidiary of the US-based AMDL, Inc. (later renamed Radient Pharmaceuticals Corp). The company's operations were primarily focused on the Chinese domestic market and the development of products for the holistic health sector. Following the financial difficulties and eventual decline of its parent company, Radient Pharmaceuticals, YYB's active status has ceased.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangbian Yiqiao Biochemistry Pharmacy.